Literature DB >> 25379993

Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study.

Fiona McKenzie1, Pietro Ferrari, Heinz Freisling, Veronique Chajès, Sabina Rinaldi, Jordi de Batlle, Christina C Dahm, Kim Overvad, Laura Baglietto, Laureen Dartois, Laure Dossus, Pagona Lagiou, Dimitrios Trichopoulos, Antonia Trichopoulou, Vittorio Krogh, Salvatore Panico, Rosario Tumino, Stefano Rosso, H B As Bueno-de-Mesquita, Anne May, Petra H Peeters, Elisabete Weiderpass, Genevieve Buckland, Maria-Jose Sanchez, Carmen Navarro, Eva Ardanaz, Anne Andersson, Malin Sund, Ulrika Ericson, Elisabet Wirfält, Tim J Key, Ruth C Travis, Marc Gunter, Elio Riboli, Anne-Claire Vergnaud, Isabelle Romieu.   

Abstract

Breast cancer is the most common cancer among women and prevention strategies are needed to reduce incidence worldwide. A healthy lifestyle index score (HLIS) was generated to investigate the joint effect of modifiable lifestyle factors on postmenopausal breast cancer risk. The study included 242,918 postmenopausal women from the multinational European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, with detailed information on diet and lifestyle assessed at baseline. The HLIS was constructed from five factors (diet, physical activity, smoking, alcohol consumption and anthropometry) by assigning scores of 0-4 to categories of each component, for which higher values indicate healthier behaviours. Hazard ratios (HR) were estimated by Cox proportional regression models. During 10.9 years of median follow-up, 7,756 incident breast cancer cases were identified. There was a 3% lower risk of breast cancer per point increase of the HLIS. Breast cancer risk was inversely associated with a high HLIS when fourth versus second (reference) categories were compared [adjusted HR = 0.74; 95% confidence interval (CI): 0.66-0.83]. The fourth versus the second category of the HLIS was associated with a lower risk for hormone receptor double positive (adjusted HR = 0.81, 95% CI: 0.67-0.98) and hormone receptor double negative breast cancer (adjusted HR = 0.60, 95% CI: 0.40-0.90). Findings suggest having a high score on an index of combined healthy behaviours reduces the risk of developing breast cancer among postmenopausal women. Programmes which engage women in long term health behaviours should be supported.
© 2014 UICC.

Entities:  

Keywords:  Europe; breast cancer; healthy index; lifestyle; prospective studies

Mesh:

Year:  2014        PMID: 25379993     DOI: 10.1002/ijc.29315

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  35 in total

1.  Relationship between body mass index and incidence of breast cancer.

Authors:  Hai-Tao Li; Xing-Hua Han; Ying-Xin Liu; Kai-Ming Leng; Guo-Min Dong
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 2.  Modifiable Lifestyle Factors: Opportunities for (Hereditary) Breast Cancer Prevention - a Narrative Review.

Authors:  Jacqueline Lammert; Sabine Grill; Marion Kiechle
Journal:  Breast Care (Basel)       Date:  2018-04-20       Impact factor: 2.860

3.  An estrogen-related lifestyle score is associated with risk of postmenopausal breast cancer in the PLCO cohort.

Authors:  Mark A Guinter; Alexander C McLain; Anwar T Merchant; Dale P Sandler; Susan E Steck
Journal:  Breast Cancer Res Treat       Date:  2018-04-12       Impact factor: 4.872

4.  Healthy lifestyle and cancer risk among Chinese population in the Dongfeng-Tongji cohort.

Authors:  Yangting He; Yansen Bai; Sheng Wei; Jing Yuan; Youjie Wang; Weihong Chen; Ping Yao; Xiaoping Miao; Yuan Liang; Xiaomin Zhang; Meian He; Shaofa Nie; Handong Yang; Tangchun Wu; Huan Guo; Li Liu
Journal:  Ann Med       Date:  2020-07-30       Impact factor: 4.709

5.  Metabolic signature of healthy lifestyle and its relation with risk of hepatocellular carcinoma in a large European cohort.

Authors:  Nada Assi; Marc J Gunter; Duncan C Thomas; Michael Leitzmann; Magdalena Stepien; Véronique Chajès; Thierry Philip; Paolo Vineis; Christina Bamia; Marie-Christine Boutron-Ruault; Torkjel M Sandanger; Amaia Molinuevo; Hendriek Boshuizen; Anneli Sundkvist; Tilman Kühn; Ruth Travis; Kim Overvad; Elio Riboli; Augustin Scalbert; Mazda Jenab; Vivian Viallon; Pietro Ferrari
Journal:  Am J Clin Nutr       Date:  2018-07-01       Impact factor: 7.045

6.  Are Metabolic Signatures Mediating the Relationship between Lifestyle Factors and Hepatocellular Carcinoma Risk? Results from a Nested Case-Control Study in EPIC.

Authors:  Nada Assi; Duncan C Thomas; Michael Leitzmann; Magdalena Stepien; Véronique Chajès; Thierry Philip; Paolo Vineis; Christina Bamia; Marie-Christine Boutron-Ruault; Torkjel M Sandanger; Amaia Molinuevo; Hendriek C Boshuizen; Anneli Sundkvist; Tilman Kühn; Ruth C Travis; Kim Overvad; Elio Riboli; Marc J Gunter; Augustin Scalbert; Mazda Jenab; Pietro Ferrari; Vivian Viallon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-03-21       Impact factor: 4.254

7.  The Combined Association of Modifiable Risk Factors with Breast Cancer Risk in the Women's Health Initiative.

Authors:  Rhonda Arthur; Sylvia Wassertheil-Smoller; JoAnn E Manson; Juhua Luo; Linda Snetselaar; Theresa Hastert; Bette Caan; Lihong Qi; Thomas Rohan
Journal:  Cancer Prev Res (Phila)       Date:  2018-02-26

8.  Genetic Factors, Adherence to Healthy Lifestyle Behavior, and Risk of Invasive Breast Cancer Among Women in the UK Biobank.

Authors:  Rhonda S Arthur; Tao Wang; Xiaonan Xue; Victor Kamensky; Thomas E Rohan
Journal:  J Natl Cancer Inst       Date:  2020-09-01       Impact factor: 13.506

9.  When Diet and Exercise Aren't Enough: The Added Benefits of Connection, Community, and Psychosocial Support in Navigating Breast Cancer Treatment.

Authors:  Cindy Geyer
Journal:  Am J Lifestyle Med       Date:  2017-06-14

10.  Healthy lifestyle and the risk of pancreatic cancer in the EPIC study.

Authors:  Sabine Naudin; Vivian Viallon; Dana Hashim; Heinz Freisling; Mazda Jenab; Elisabete Weiderpass; Flavie Perrier; Fiona McKenzie; H Bas Bueno-de-Mesquita; Anja Olsen; Anne Tjønneland; Christina C Dahm; Kim Overvad; Francesca R Mancini; Vinciane Rebours; Marie-Christine Boutron-Ruault; Verena Katzke; Rudolf Kaaks; Manuela Bergmann; Heiner Boeing; Eleni Peppa; Anna Karakatsani; Antonia Trichopoulou; Valeria Pala; Giovana Masala; Salvatore Panico; Rosario Tumino; Carlotta Sacerdote; Anne M May; Carla H van Gils; Charlotta Rylander; Kristin Benjaminsen Borch; María Dolores Chirlaque López; Maria-Jose Sánchez; Eva Ardanaz; José Ramón Quirós; Pilar Amiano Exezarreta; Malin Sund; Isabel Drake; Sara Regnér; Ruth C Travis; Nick Wareham; Dagfinn Aune; Elio Riboli; Marc J Gunter; Eric J Duell; Paul Brennan; Pietro Ferrari
Journal:  Eur J Epidemiol       Date:  2019-09-28       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.